Biomarkers for risk stratification of malignancy-prone precancerous conditions: focusing on gastric intestinal metaplasia

Medical Review · Published 2026-07-27 · DOI 10.1515/mr-2026-0022

Free full text

Authors (7)

Zhongyang Zhang, Xianchun Gao, Reyila Abudurousuli, Jun Yu, Dai Zhang, Peng Li, Yongzhan Nie

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zhang, Z., Gao, X., Abudurousuli, R., et al. (2026). Biomarkers for risk stratification of malignancy-prone precancerous conditions: focusing on gastric intestinal metaplasia. Medical Review. https://doi.org/10.1515/mr-2026-0022

Related articles

• When biomarkers for major depressive disorder remain elusive · Medical Review · 2024 · Same journal
• Gaseous biomarkers speak medical conditions · Medical Review · 2026 · Same journal
• Unfolding ecDNA as a pan-cancer therapeutic target · Medical Review · 2025 · Same journal
• The AI doctor will see you soon: from assistants to autonomous practitioners · Medical Review · 2025 · Same journal
• Target discovery-directed pharmacological mechanism elucidation of bioactive natural products · Medical Review · 2025 · Same journal
• Severe trauma care: advances and future directions in diagnostic and therapeutic techniques and information technology support · Medical Review · 2026 · Same journal
• Artificial intelligence-based software as a medical device: regulatory evolution toward continuous oversight · Medical Review · 2026 · Same journal
• Proactive personalized early warning systems: the next frontier in climate–health preparedness · Medical Review · 2026 · Same journal
• Transfer RNA-derived small RNAs (tsRNAs) in Alzheimer’s disease: emerging mechanisms and diagnostic potential · Medical Review · 2026 · Same journal
• Obesity: current developments in mechanisms, diagnosis, classification and the evolution of personalized management · Medical Review · 2026 · Same journal